N. I. Konyashina

Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics.

F. Ataullakhanov, M. Panteleev, A. Balandina, 2013, Thrombosis research.

The results of the use of Octofactor in patients with moderate and severe hemophilia A (data from a prospective, multicenter, open-label, observational study)

S. Morozov, E. Schiller, N. Zozulya, 2019, Russian Journal of Pediatric Hematology and Oncology.

Results of a prospective observation on the use of a coagulation factor concentrate VIII concentrate (Octanate®) for the induction of immunological tolerance in patients with an inhibitory form of hemophilia A

V. V. Vdovin, N. Zozulya, P. Svirin, 2020, Russian Journal of Pediatric Hematology and Oncology.

The use of thromboelastography , thrombin generation test and clotting tests to evaluate the efficacy of hemostatic therapy with recombinant activated factor VII in hemophilia patients with inhibitor

V. Zorenko, T. Polyanskaya, D. Kudlay, 2017 .

New Missense Mutation His2026Arg in the Factor VIII Gene Was Revealed in Two Female Patients with Clinical Manifestation of Hemophilia A

V. I. Ershov, N. Zozulya, V. Surin, 2018, Russian Journal of Genetics.

New Missense Mutation His2026Arg in the Factor VIII Gene Was Revealed in Two Female Patients with Clinical Manifestation of Hemophilia A

V. I. Ershov, N. Zozulya, V. Surin, 2018, Russian Journal of Genetics.

Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency

N. Zozulya, V. Surin, E. B. Orel, 2021 .

CONGENITAL FACTOR V DEFICIENCY: CASE REPORTS

N. Zozulya, V. Surin, V. Surin, 2019, Russian journal of hematology and transfusiology.